Aureus Pharma has released DDI Predict, a software application to assess the risk of potential drug-drug interactions.
DDI Predict automatically calculates the risk of drug-drug interactions associated with Cytochrome P450s via a computer algorithm and provides in a manner of minutes, a graphical report containing all potential drug-drug interactions between a potential drug candidate and a large panel of other drugs/compounds. This analysis of potential DDI risk is based on the latest FDA risk classification.
The input to the application consists of experimental data for a proprietary compound and prior experimental knowledge derived from Aureus’ AurScope ADME knowledge database. This contains more than 16,000 compounds, 230,000 biological data points, analysed from more than 9,000 articles and FDA documents.